TWD 101.5
(-1.93%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 51.64 Million TWD | -8.78% |
2022 | 56.61 Million TWD | 85.75% |
2021 | 30.47 Million TWD | -10.0% |
2020 | 33.86 Million TWD | -14.62% |
2019 | 39.66 Million TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 46.4 Million TWD | -10.15% |
2024 Q2 | 26 Million TWD | 2.76% |
2023 Q4 | 51.64 Million TWD | 2.54% |
2023 FY | 51.64 Million TWD | -8.78% |
2023 Q3 | 50.36 Million TWD | -9.26% |
2023 Q1 | 54.23 Million TWD | -4.19% |
2023 Q2 | 55.5 Million TWD | 2.33% |
2022 Q3 | 55.36 Million TWD | 0.0% |
2022 FY | 56.61 Million TWD | 85.75% |
2022 Q4 | 56.61 Million TWD | 2.25% |
2021 FY | 30.47 Million TWD | -10.0% |
2020 FY | 33.86 Million TWD | -14.62% |
2019 FY | - TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
BIONET Corp. | 45.01 Million TWD | -14.722% |
DIVA Laboratories, Ltd. | 2.53 Million TWD | -1939.534% |
Genetics Generation Advancement Corp. | 49.29 Million TWD | -4.755% |
Welgene Biotech Co.,Ltd. | 154.34 Million TWD | 66.542% |
TFBS Bioscience Inc. | 131.77 Million TWD | 60.81% |